PP 4.19 – 00021 Impact of SARS-COV-2-Mediated CD4 T Cell Activation HIV DNA Persistence In Vivo

por Deveau, T.-M., Peluso, M., Buck, A., Kumar, N., Henrich, T.
Publicado 2022

Allosteric inhibition of a stem cell RNA-binding protein by an intermediary metabolite

por Clingman, Carina C, Deveau, Laura M, Hay, Samantha A, Genga, Ryan M, Shandilya, Shivender MD, Massi, Francesca, Ryder, Sean P
Publicado 2014

The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors

por Romano, Keith P., Ali, Akbar, Aydin, Cihan, Soumana, Djade, Özen, Ayşegül, Deveau, Laura M., Silver, Casey, Cao, Hong, Newton, Alicia, Petropoulos, Christos J., Huang, Wei, Schiffer, Celia A.
Publicado 2012

An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19

por Rappazzo, C. Garrett, Tse, Longping V., Kaku, Chengzi I., Wrapp, Daniel, Sakharkar, Mrunal, Huang, Deli, Deveau, Laura M., Yockachonis, Thomas J., Herbert, Andrew S., Battles, Michael B., O’Brien, Cecilia M., Brown, Michael E., Geoghegan, James C., Belk, Jonathan, Peng, Linghang, Yang, Linlin, Scobey, Trevor D., Burton, Dennis R., Nemazee, David, Dye, John M., Voss, James E., Gunn, Bronwyn M., McLellan, Jason S., Baric, Ralph S., Gralinski, Lisa E., Walker, Laura M.
Publicado 2020

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

por Rappazzo, C. Garrett, Tse, Longping V., Kaku, Chengzi I., Wrapp, Daniel, Sakharkar, Mrunal, Huang, Deli, Deveau, Laura M., Yockachonis, Thomas J., Herbert, Andrew S., Battles, Michael B., O’Brien, Cecilia M., Brown, Michael E., Geoghegan, James C., Belk, Jonathan, Peng, Linghang, Yang, Linlin, Hou, Yixuan, Scobey, Trevor D., Burton, Dennis R., Nemazee, David, Dye, John M., Voss, James E., Gunn, Bronwyn M., McLellan, Jason S., Baric, Ralph S., Gralinski, Lisa E., Walker, Laura M.
Publicado 2021